DE69927688D1 - Antivirales Mittel in Kombination mit Strahlentherapie zur Verwendung in der Behandlung von Krebs - Google Patents

Antivirales Mittel in Kombination mit Strahlentherapie zur Verwendung in der Behandlung von Krebs

Info

Publication number
DE69927688D1
DE69927688D1 DE69927688T DE69927688T DE69927688D1 DE 69927688 D1 DE69927688 D1 DE 69927688D1 DE 69927688 T DE69927688 T DE 69927688T DE 69927688 T DE69927688 T DE 69927688T DE 69927688 D1 DE69927688 D1 DE 69927688D1
Authority
DE
Germany
Prior art keywords
treatment
cancer
combination
radiotherapy
antiviral agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69927688T
Other languages
English (en)
Other versions
DE69927688T2 (de
Inventor
Jean Bourhis
Bassam Abdulkarim
Eric Deutsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Gustave Roussy (IGR)
Universite Paris Sud Paris 11
Original Assignee
Institut Gustave Roussy (IGR)
Universite Paris Sud Paris 11
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Gustave Roussy (IGR), Universite Paris Sud Paris 11 filed Critical Institut Gustave Roussy (IGR)
Application granted granted Critical
Publication of DE69927688D1 publication Critical patent/DE69927688D1/de
Publication of DE69927688T2 publication Critical patent/DE69927688T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DE69927688T 1999-11-04 1999-11-04 Antivirales Mittel in Kombination mit Strahlentherapie zur Verwendung in der Behandlung von Krebs Expired - Lifetime DE69927688T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99402748A EP1097720B1 (de) 1999-11-04 1999-11-04 Antivirales Mittel in Kombination mit Strahlentherapie zur Verwendung in der Behandlung von Krebs

Publications (2)

Publication Number Publication Date
DE69927688D1 true DE69927688D1 (de) 2006-02-23
DE69927688T2 DE69927688T2 (de) 2006-07-06

Family

ID=8242168

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69927688T Expired - Lifetime DE69927688T2 (de) 1999-11-04 1999-11-04 Antivirales Mittel in Kombination mit Strahlentherapie zur Verwendung in der Behandlung von Krebs

Country Status (7)

Country Link
US (2) US6723712B2 (de)
EP (2) EP1097720B1 (de)
AT (1) ATE306281T1 (de)
AU (1) AU2158601A (de)
DE (1) DE69927688T2 (de)
ES (1) ES2251168T3 (de)
WO (1) WO2001032215A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030158220A1 (en) * 1997-11-03 2003-08-21 Foss Joseph F. Use of methylnaltrexone and related compounds to treat chronic opioid use side effects
US20050113324A1 (en) * 2003-01-15 2005-05-26 Bondarev Igor E. Modulation of line-1 reverse transcriptase
PT2368553E (pt) * 2003-04-08 2015-03-03 Progenics Pharm Inc Formulações farmacêuticas contendo metilnaltrexona
EP1861096B1 (de) * 2005-03-07 2018-12-26 The University of Chicago Verwendung von opioid-antagonisten zur abschwächung der proliferation und migration von endothelzellen
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
US8524731B2 (en) * 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
AR057035A1 (es) * 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
US20060107365A1 (en) * 2006-01-31 2006-05-18 Pioneer Hi-Bred International, Inc. Soybean variety XB37U06
TW200817048A (en) * 2006-09-08 2008-04-16 Wyeth Corp Dry powder compound formulations and uses thereof
WO2008080223A1 (en) * 2006-12-28 2008-07-10 Migenix Inc. Compositions and methods for treating hyperproliferative disease
PT2565195E (pt) 2007-03-29 2015-07-28 Wyeth Llc Antagonistas e receptor opióide periférico e respectivas utilizações
CN101801979A (zh) 2007-03-29 2010-08-11 普罗热尼奇制药公司 (r)-n-溴化甲基纳曲酮的晶体形式及其用途
PE20130480A1 (es) 2007-03-29 2013-05-08 Progenics Pharm Inc Compuestos heterociclicos como antagonistas del receptor opioide periferico
JP5358587B2 (ja) * 2008-02-06 2013-12-04 プロジェニックス・ファーマシューティカルス・インコーポレイテッド （ｒ），（ｒ）−２，２’−ビス−メチルナルトレキソンの製造及び用途
CA2719134C (en) 2008-03-21 2015-06-30 The University Of Chicago Treatment with opioid antagonists and mtor inhibitors
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
EP2371369A1 (de) 2010-04-01 2011-10-05 Institut Gustave Roussy (IGR) EGFR-Inhibitor und antivirales Mittel zur gleichzeitigen, getrennten oder aufeinanderfolgenden Verwendung bei der Behandlung und/oder Vorbeugung und/oder Abschwächung von Krebs
US20130178517A1 (en) * 2010-07-09 2013-07-11 Richard L. Atkinson Methods And Compositions For Treatment Of Lipogenic Virus Related Conditions

Also Published As

Publication number Publication date
DE69927688T2 (de) 2006-07-06
US20020193339A1 (en) 2002-12-19
WO2001032215A1 (en) 2001-05-10
US20040192637A1 (en) 2004-09-30
ES2251168T3 (es) 2006-04-16
EP1097720A1 (de) 2001-05-09
AU2158601A (en) 2001-05-14
EP1237576A1 (de) 2002-09-11
US6723712B2 (en) 2004-04-20
EP1097720B1 (de) 2005-10-12
ATE306281T1 (de) 2005-10-15

Similar Documents

Publication Publication Date Title
DE69927688D1 (de) Antivirales Mittel in Kombination mit Strahlentherapie zur Verwendung in der Behandlung von Krebs
AU2002351196A1 (en) Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
DE69942827D1 (de) Verwendung der epothilons zur behandlung der krebs
ATE277058T1 (de) Polyazomacrocyclofluoromonoalkylphosphensäure, ihre komplexe zur verwendung als kontrastmittel
ATE408601T1 (de) Fredericamycin-derivate
NO20000752L (no) Metode for forhindring eller behandling av østrogen-avhengige sykdommer og forstyrrelser
ATE414512T1 (de) Kombinationstherapie zur behandlung von krebs
ATE362374T1 (de) Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust
DE60136826D1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
ATE397000T1 (de) Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs
DE60030554T8 (de) Verwendungen von et743 zur behandlung von krebs
PT971922E (pt) Compostos de tetra-hidropirido
NO20053903D0 (no) Nukleotidlipidesterderivater.
ATE288498T1 (de) Methoden zur inhibierung von helicobacter pylori
ATE326232T1 (de) Mittel zur vorbeugung bzw. heilung der stomatitis
HK1050533A1 (en) Substituted pyrroles as antiproliferative agents for the treatment of cancer.
ATE415165T1 (de) Kombinierte tumortherapie auf der basis von distamycin-acryloyl derivate und antimetabolische mitteln
AU2003249999A8 (en) 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours
CY1115806T1 (el) Παραγωγα του κυκλικου eστερα uk-2a χρησιμα στην προληψη ή την αντιμετωπιση μυκητολογικων ασθενειων
DE60024450D1 (de) Modulierung der angiogenese durch verwendung von anti-angiogenischen angiotensin-7 und dafür kodierende polynukleotiden zur behandlung von tumoren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R074 Re-establishment allowed

Ref document number: 1097720

Country of ref document: EP